TAK-379
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for TAK-379, covering 2016-06-22 to 2016-06-22. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy and Safety of TAK-379 in Adult Subjects With Type 2 Diabetes Mellitus [Phase 2]